-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Contineum Therapeutics, Raises Price Target to $16

Benzinga·05/14/2026 16:45:56
Listen to the news
Morgan Stanley analyst Jeffrey Hung maintains Contineum Therapeutics (NASDAQ:CTNM) with a Equal-Weight and raises the price target from $14 to $16.